Your browser is no longer supported. Please, upgrade your browser.
Settings
FLKS FLEX PHARMA, INC. daily Stock Chart
FLKS [NASD]
FLEX PHARMA, INC.
Index- P/E- EPS (ttm)-2.44 Insider Own21.90% Shs Outstand18.27M Perf Week0.56%
Market Cap65.77M Forward P/E- EPS next Y-2.76 Insider Trans0.44% Shs Float13.03M Perf Month-16.86%
Income-39.50M PEG- EPS next Q-0.62 Inst Own48.70% Short Float3.72% Perf Quarter-19.82%
Sales1.00M P/S65.77 EPS this Y-17.10% Inst Trans-0.09% Short Ratio7.09 Perf Half Y-33.21%
Book/sh3.57 P/B1.01 EPS next Y-3.40% ROA-52.90% Target Price17.75 Perf Year-69.77%
Cash/sh3.34 P/C1.08 EPS next 5Y- ROE-55.60% 52W Range3.01 - 13.97 Perf YTD-31.82%
Dividend- P/FCF- EPS past 5Y- ROI-67.30% 52W High-74.23% Beta-
Dividend %- Quick Ratio15.90 Sales past 5Y- Gross Margin34.40% 52W Low19.60% ATR0.31
Employees30 Current Ratio16.10 Sales Q/Q- Oper. Margin- RSI (14)46.40 Volatility13.03% 8.52%
OptionableYes Debt/Eq0.00 EPS Q/Q6.20% Profit Margin- Rel Volume2.43 Prev Close3.56
ShortableYes LT Debt/Eq0.00 EarningsMar 08 BMO Payout- Avg Volume68.39K Price3.60
Recom2.00 SMA20-5.26% SMA50-12.31% SMA200-49.76% Volume159,900 Change1.12%
Oct-14-16Downgrade Cantor Fitzgerald Buy → Hold
Apr-14-15Initiated H.C. Wainwright Buy $40
Feb-23-15Initiated ROTH Capital Buy $27
Apr-26-17 08:00AM  FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND Business Wire +15.96%
Apr-19-17 08:00AM  Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting Business Wire
Apr-05-17 08:00AM  Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development Business Wire
08:00AM  Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Mar-23-17 07:45AM  Newly-Published Study Reinforces Efficacy Of HOTSHOT® In Preventing And Treating Muscle Cramps PR Newswire
Mar-14-17 01:04PM  FLEX PHARMA, INC. Financials
Mar-09-17 09:12AM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT Thomson Reuters StreetEvents
09:12AM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT
Mar-08-17 08:30AM  Flex Pharma Inc Earnings Call scheduled for 8:30 am ET today -16.67%
07:52AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:16AM  Flex Pharma reports 4Q loss Associated Press
07:16AM  Flex Pharma reports 4Q loss
07:07AM  Q4 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Year End 2016 Financial Results Business Wire
Mar-01-17 03:36PM  Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017 Business Wire
Feb-23-17 08:44AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-15-17 02:52PM  Champion Triathlete Finds Solution For Struggle With Muscle Cramps PR Newswire
Feb-07-17 01:31PM  Flex Pharma to Present at the BIO CEO & Investor Conference Business Wire
Jan-24-17 07:30AM  Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases Business Wire
Dec-20-16 12:53PM  Champion Pro Football Fullback Goes On The Offense Against Game-Changing Cramps PR Newswire
Dec-15-16 01:04PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial
Dec-12-16 06:01PM  Do Hedge Funds Love Vishay Precision Group Inc (VPG)? at Insider Monkey -6.20%
Nov-21-16 06:07PM  Flex Pharma to Present at the Piper Jaffray 28th Annual Healthcare Conference Business Wire
Nov-15-16 08:03AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-09-16 12:00PM  Flex Pharma to Present at the Jefferies 2016 Healthcare Conference Business Wire
Nov-03-16 07:56AM  Edited Transcript of FLKS earnings conference call or presentation 2-Nov-16 12:45pm GMT -5.27%
Nov-02-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today
08:09AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:46AM  Flex Pharma reports 3Q loss
07:07AM  Q3 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Third Quarter 2016 Financial Results Business Wire
Oct-26-16 09:00AM  Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016 Business Wire
Oct-14-16 10:45AM  ETFs with exposure to Flex Pharma, Inc. : October 14, 2016 -15.90%
08:45AM  Flex Pharma downgraded by Cantor Fitzgerald
Oct-13-16 08:45AM  Flex Pharma Provies FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update Call scheduled for 8:45 am ET today -24.73%
08:02AM  FLEX PHARMA, INC. Files SEC form 8-K, Other Events
06:30AM  Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update Business Wire
Sep-13-16 07:30AM  Flex Pharma Initiates Phase 2 Efficacy Study in Amyotrophic Lateral Sclerosis Business Wire
Sep-01-16 08:30AM  Flex Pharma Presenting at Upcoming Investor Conferences in September 2016 Business Wire
Aug-26-16 04:12PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers -7.92%
04:05PM  Flex Pharma Announces Scientific Advisory Board Appointment and Management Change Business Wire
Aug-04-16 09:13AM  Edited Transcript of FLKS earnings conference call or presentation 3-Aug-16 12:45pm GMT
Aug-03-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today +6.68%
08:09AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:30AM  Flex Pharma reports 2Q loss
07:07AM  Q2 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Second Quarter 2016 Financial Results Business Wire
Jul-27-16 08:30AM  Flex Pharma to Report Second Quarter 2016 Results on August 3, 2016 Business Wire
Jul-26-16 08:00AM  Flex Pharma Completes Enrollment of Human Proof-of Concept Efficacy Study in Nocturnal Leg Cramps Business Wire
Jul-06-16 08:30AM  Flex Pharma to Present at the Cantor Fitzgerald Healthcare Conference Business Wire
Jun-15-16 08:00AM  Flex Pharma Initiates Phase 2 Efficacy Study in Multiple Sclerosis Business Wire
Jun-10-16 03:31PM  FLEX PHARMA, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
03:23PM  FLEX PHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-06-16 02:26PM  Flex Pharma, Inc. :FLKS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-03-16 08:00AM  Flex Pharma Presenting at Upcoming Investor Conferences in June 2016 Business Wire
Jun-02-16 08:00AM  Scientific Breakthrough In Sports Nutrition To Change The Game For Millions Of Endurance Athletes PR Newswire
07:30AM  Flex Pharma Launches First Consumer Product Scientifically Proven to Prevent and Treat Muscle Cramps Business Wire
May-25-16 05:04PM   CEOs Make Big Buys of Their Companies Stocks
08:00AM  Flex Pharma Initiates Human Efficacy Study with Single Molecule Tablet in Nocturnal Leg Cramps Business Wire
May-17-16 08:40AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
May-13-16 04:23PM  FLEX PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Of
May-04-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today
08:11AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:16AM  Flex Pharma reports 1Q loss
07:07AM  Q1 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports First Quarter 2016 Financial Results Business Wire
Apr-27-16 08:00AM  Flex Pharma to Report First Quarter 2016 Results on May 4, 2016 Business Wire
Apr-19-16 04:40PM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:01PM  Flex Pharmas Positive Human NLC Study Selected for Presentation at AAN Annual Meeting Business Wire
Apr-06-16 08:00AM  Flex Pharma Collaborator Penn State Presents Positive Human Muscle Cramp Data Business Wire
Mar-31-16 03:59PM  FLEX PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Mar-30-16 02:52PM  5 Stocks Insiders Love Right Now at TheStreet
Mar-28-16 06:45PM  CEO of Flex Pharma Buys Nearly 50,000 Shares
Mar-27-16 10:20AM  Big Biotech Trades Dominate Recent Insider Buying: Seattle Genetics, Minerva Neurosciences, OvaScience and More at 24/7 Wall St.
Mar-18-16 07:05AM  The cult marketing plan behind one Boston biotechs pending product launch at bizjournals.com
Mar-14-16 08:15AM  Flex Pharma (FLKS) Jumps: Stock Adds 16.7% in Session +32.02%
08:00AM  Flex Pharma Positive Human NLC Study Selected for Late-Breaking Presentation at AAN Annual Meeting Business Wire
Mar-09-16 03:59PM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-16 1:30pm GMT
02:43PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-08-16 08:30AM  Flex Pharma Inc Earnings Call scheduled for 8:30 am ET today
07:40AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:15AM  Flex Pharma reports 4Q loss
07:07AM  Q4 2015 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Year End 2015 Financial Results Business Wire
Mar-07-16 04:01PM  Michelle V. Stacy Joins Flex Pharmas Board of Directors Business Wire
Mar-01-16 08:00AM  Flex Pharma to Report Full Year 2015 Results on March 8, 2016 Business Wire
Feb-02-16 09:00AM  Flex Pharma, Inc. Announces Positive Human Efficacy in Nocturnal Leg Cramp Study - Call scheduled for 9:00 am ET today
08:17AM  FLEX PHARMA, INC. Files SEC form 8-K, Other Events
07:00AM  Flex Pharma Announces Positive Human Efficacy in Nocturnal Leg Cramp Study Business Wire
Jan-28-16 09:00AM  The Life Sciences Report's 2016 Small-Cap Biotech Watchlist Marketwired -7.89%
Jan-06-16 01:02PM  Flex Pharma Could Still Double From Here, Roth Analyst Says
07:00AM  Enrollment Completed in Flex Pharmas Exploratory Human Nocturnal Leg Cramp Study Business Wire
Dec-22-15 03:59PM  FLEX PHARMA, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
08:40AM  Flex Pharma (FLKS) Looks Good: Stock Adds 5.9% in Session
Dec-21-15 08:00AM  Flex Pharma Added to NASDAQ Biotechnology Index Business Wire +5.90%
Dec-17-15 12:00PM  Not slowing down: Here are all the Massachusetts biotechs that held IPOs in 2015 at bizjournals.com
Dec-16-15 07:30AM  A Change in Tides - Complementary Research on CTI BioPharma, Flex Pharma, Comstock Resources and Tristate Capital Holdings Accesswire
Dec-09-15 08:00AM  Flex Pharma Presents at the 26th International Symposium on ALS/MND Business Wire
Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps and spasms associated with neurological conditions and exercise-associated muscle cramps in the United States. The company operates through two segments, Consumer Operations and Drug Development. Its lead drug candidate includes FLX-787, a single molecule, chemically synthesized, and transient receptor potential ion channel activator, which is in exploratory Phase 2 clinical trial in Australia for the treatment of patients with multiple sclerosis and amyotrophic lateral sclerosis. The company also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. It markets and sells its HOTSHOT product online through its e-commerce Website, as well as through third-party Websites. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Westphal Christoph HPresident and CEONov 08Buy7.317,00051,1703,941,118Nov 08 04:23 PM
Westphal Christoph HPresident and CEONov 07Buy5.708,87050,5593,934,118Nov 07 04:43 PM
McCabe John P.VP of Finance & TreasurerNov 07Buy6.011,6509,9171,650Nov 07 04:40 PM
Westphal Christoph HPresident and CEOJun 23Buy11.282,70030,4563,212,861Jun 24 09:03 AM
Westphal Christoph HPresident and CEOJun 22Buy11.032,90031,9873,210,161Jun 22 05:40 PM
Westphal Christoph HPresident and CEOJun 21Buy11.072,80030,9963,207,261Jun 22 05:40 PM
Westphal Christoph HPresident and CEOJun 20Buy11.373,00034,1103,204,461Jun 21 10:04 AM
Westphal Christoph HPresident and CEOJun 17Buy10.983,00032,9403,201,461Jun 21 10:04 AM
Westphal Christoph HPresident and CEOJun 14Buy11.193,00033,5703,192,661Jun 15 10:03 AM
Westphal Christoph HPresident and CEOJun 13Buy11.902,90034,5103,189,661Jun 15 10:03 AM
Westphal Christoph HPresident and CEOJun 10Buy11.833,00035,4903,186,761Jun 13 09:30 AM
Westphal Christoph HPresident and CEOJun 09Buy12.043,00036,1203,183,761Jun 13 09:30 AM
Westphal Christoph HPresident and CEOJun 08Buy12.242,90035,4963,180,761Jun 09 12:29 PM
Westphal Christoph HPresident and CEOJun 07Buy12.263,00036,7803,177,861Jun 09 12:29 PM
Westphal Christoph HPresident and CEOJun 02Buy13.225,00066,1003,168,861Jun 02 05:54 PM
Westphal Christoph HPresident and CEOJun 01Buy12.765,00063,8003,163,861Jun 02 05:54 PM
Westphal Christoph HPresident and CEOMay 31Buy12.665,00063,3003,158,861Jun 01 10:19 AM
Westphal Christoph HPresident and CEOMay 27Buy12.6817,300219,3643,153,861Jun 01 10:19 AM
Westphal Christoph HPresident and CEOMay 26Buy12.5316,300204,2393,136,561May 27 12:42 PM
Westphal Christoph HPresident and CEOMay 25Buy13.2512,300162,9753,120,261May 27 12:42 PM
Westphal Christoph HPresident and CEOMay 24Buy12.5016,967212,0883,107,961May 24 05:20 PM
Westphal Christoph HPresident and CEOMay 23Buy12.3113,367164,5483,090,994May 24 05:20 PM
Westphal Christoph HPresident and CEOMay 20Buy11.441,00011,4403,077,627May 23 11:42 AM
Westphal Christoph HPresident and CEOMay 19Buy11.006,91476,0543,076,627May 23 11:42 AM
Westphal Christoph HPresident and CEOMay 18Buy11.0515,200167,9603,069,713May 19 08:44 AM
Westphal Christoph HPresident and CEOMay 17Buy11.1418,200202,7483,054,513May 19 08:44 AM
Westphal Christoph HPresident and CEOMay 16Buy10.408,20085,2803,036,313May 17 10:55 AM
Westphal Christoph HPresident and CEOMay 13Buy10.097,26973,3443,028,113May 17 10:55 AM
Westphal Christoph HPresident and CEOMay 12Buy9.9416,097160,0043,020,844May 13 10:00 AM
Westphal Christoph HPresident and CEOMay 11Buy10.3314,120145,8603,004,747May 13 10:00 AM
Westphal Christoph HPresident and CEOMay 10Buy10.1412,577127,5312,990,627May 11 10:15 AM
Westphal Christoph HPresident and CEOMay 09Buy9.8017,532171,8142,978,050May 11 10:15 AM